抑郁异质性与生物学基础:面向免疫代谢性抑郁
本综述指出抑郁患者存在炎症增加和能量调节神经内分泌信号紊乱等稳态生物学通路失调,这些失调与不典型行为症状(食欲亢进、体重增加、嗜睡、疲劳、铅样瘫痪)更一致地对应,并可能调节标准或新型治疗(如抗炎)的抗抑郁效果。文章将这些证据整合为免疫代谢性抑郁的概念模型,并提出利用该维度解析抑郁异质性、匹配患者与特定治疗以提升临床成功可能性的研究方向。
要点
- 抑郁患者存在炎症增加和能量调节神经内分泌信号紊乱等稳态生物学通路失调。
- 免疫代谢失调更一致地对应不典型行为症状(食欲亢进、体重增加、嗜睡、疲劳、铅样瘫痪)。
- 免疫代谢失调可能调节标准或新型(如抗炎)治疗的抗抑郁效果。
核心结论
- 免疫代谢性抑郁的概念模型由免疫代谢生物学失调与特定行为症状聚类构成,可用于解析抑郁异质性并匹配患者与特定治疗。
研究设计与样本
- 综述类文章,检索范围未在原文中明确报告。
主要发现
- 抑郁患者存在炎症增加和能量调节神经内分泌信号(如瘦素、胰岛素)紊乱等稳态生物学通路失调。
- 这些生物学失调更一致地对应反映能量摄入/支出平衡改变的不典型行为症状(食欲亢进、体重增加、嗜睡、疲劳、铅样瘫痪)。
- 免疫代谢失调可能解释抑郁与心脏代谢疾病(如肥胖、代谢综合征、糖尿病)的显著共病,并可能调节标准或新型(如抗炎)治疗的抗抑郁效果。
临床怎么用
- 可利用免疫代谢性抑郁维度解析抑郁异质性,并可能将患者亚组匹配至更可能临床成功的特定治疗。
局限性
- 原文未明确报告综述的检索范围等局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epidemiological evidence indicates the presence of dysregulated homeostatic biological pathways in depressed patients, such as increased inflammation and disrupted energy-regulating neuroendocrine signaling (e.g., leptin, insulin). Alterations in these biological pathways may explain the considerable comorbidity between depression and cardiometabolic conditions (e.g., obesity, metabolic syndrome, diabetes) and represent a promising target for intervention. This review describes how immunometabolic dysregulations vary as a function of depression heterogeneity by illustrating that such biological dysregulations map more consistently to atypical behavioral symptoms reflecting altered energy intake/expenditure balance (hyperphagia, weight gain, hypersomnia, fatigue, and leaden paralysis) and may moderate the antidepressant effects of standard or novel (e.g., anti-inflammatory) therapeutic approaches. These lines of evidence are integrated in a conceptual model of immunometabolic depression emerging from the clustering of immunometabolic biological dysregulations and specific behavioral symptoms. The review finally elicits questions to be answered by future research and describes how the immunometabolic depression dimension could be used to dissect the heterogeneity of depression and potentially to match subgroups of patients to specific treatments with higher likelihood of clinical success.
引用
- Milaneschi Y, Lamers F, Berk M, et al. Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression. Biol Psychiatry. 2020. PMID: 32247527. doi:10.1016/j.biopsych.2020.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。